Cancer Immunotherapy Market is Determined to Cross US$ 145 Billion By 2022

New York, March 26, 2018:

Cancer Immunotherapy Market

The cancer immunotherapy market is expected to grow more than US$ 145 Billion by 2022; Growing at a CAGR of more than 14% in the given forecast period.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Amgen (U.S.), AstraZeneca (U.K.), F. Hoffman La-Roche Ltd. (Switzerland), Bayer AG (Germany), Bristol-Myers Squibb (U.S.), Eli Lilly and Company (U.S.), Janssen Global Services, LLC (Belgium), Merck (U.S.), Novartis (Switzerland), and Pfizer (U.S.).. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The scope of the report includes a detailed study of global and regional markets for Cancer Immunotherapy market with the reasons given for variations in the growth of the industry in certain regions.

You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/cancer-immunotherapy-market

The Cancer Immunotherapy Market has been segmented as below:

By Type Segment Analysis
Immunomodulators
Checkpoint inhibitors
Cancer vaccines
Monoclonal antibodies

By Application Analysis
Melanoma
Colorectal cancer
Prostate cancer
Head and neck cancer
Breast cancer
Lung cancer

By End-user Analysis
Hospitals
Clinics and others

By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World

This report provides:

1) An overview of the global market for cancer immunotherapy and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Discovering of new market opportunities and targeted promotional plans for cancer immunotherapy.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Request Sample Report here @: https://www.marketresearchengine.com/reportdetails/cancer-immunotherapy-market

The major driving factors of cancer immunotherapy market are as follows:

Expansion of bioinformatics tools will enhance drug development procedure
Growth in adoption of immunotherapy above other treatment alternatives
Increase in incidence rate of cancer worldwide

The restraining factors of cancer immunotherapy market are as follows:

Treatment cost is high

The cancer immunotherapy market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Table of Contents
1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Cancer Immunotherapy Market, By Product Type
7.1 Introduction
7.2 Monoclonal Antibodies
7.2.1 Naked Monoclonal Antibodies
7.2.2 Conjugated Monoclonal Antibodies
7.2.3 Bispecific Monoclonal Antibodies
7.3 Vaccines
7.3.1 Prophylactic Vaccines
7.3.2 Therapeutic Vaccines
7.4 Check Point Inhibitors
7.4.1 Cytotoxic T-Lymphocyte-Associated Protein-4 (CTLA-4)
7.4.2 Programmed Death 1 (PD-1) and Programmed Death Ligand 1 (PD-L1)
7.5 Cell Therapies
7.5.1 Chimeric Antigen Receptor (CAR) T Cell Therapy
7.5.2 Dendritic Cells
7.6 Immunomodulators
7.6.1 Granulocyte/Macrophage Colony-Stimulating Factor (GM-CSF & G-CSF)
7.6.2 Interferons (IFN)
7.6.3 Interleukins (IL)
7.6.4 Oncolytic Virus
7.6.4.1 Immunotherapy
7.6.4.1 Immunity as an Obstacle
7.6.4.2 Immunity as an Ally
7.6.4.3 Approved Products & Clinical Trails
8 Cancer Immunotherapy Market, By Application
9 Cancer Immunotherapy Market, By End User
10 Cancer Immunotherapy Market, By Region
11 Competitive Landscape
12 Company Profile
12.1 Amgen Inc.
12.2 Astrazeneca
12.3 Bayer AG
12.4 Bristol-Myers Squibb
12.5 Eli Lilly and Company
12.6 Janssen Global Services, LLC (Johnson and Johnson)
12.7 Merck
12.8 Novartis
12.9 Pfizer
12.10 F. Hoffmann-LA Roche Ltd

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.